3 completed. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow TLC599: new trials by email Literature Review of TLC599 trials Research Report on TLC599
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain TLC599, DSP, Normal Saline - Osteoarthritis of the Knee | Phase 3 | Completed | Taiwan Liposome Company | 504 | 2019-11-26 | 2024-10-08 |
| A Phase 2, Open Label, Pharmacokinetic (PK) Study of TLC599 in Subjects With Osteoarthritis of the Knee TLC599, DSP - Osteoarthritis of the Knee | Phase 2 | Completed | Taiwan Liposome Company | 102 | 2019-01-21 | 2024-10-23 |
| Single-Dose Administration Trial of TLC599 in Osteoarthritis of the Knee TLC599 - Osteoarthritis of the Knee | Phase 1 / Phase 2 | Completed | Taiwan Liposome Company | 40 | 2015-06-01 | 2022-05-06 |
Taiwan (2) · United States (2) · Australia (1)
Carl Brown, PhD (2) · Terry Tai, MD (1)